Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-25 3:03 pm Purchase | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 7,405,925 17.000% | 558,178 (+8.15%) | Filing History |
| 2022-01-21 2:15 pm Purchase | 2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO | ROYCE & ASSOCIATES LP | 2,195,634 5.050% | 2,195,634 (New Position) | Filing History |
| 2021-04-12 4:56 pm Purchase | 2021-03-31 | 13G | Meridian Bioscience, Inc. VIVO | EARNEST PARTNERS LLC | 4,341,834 10.100% | 4,341,834 (New Position) | Filing History |
| 2021-02-12 12:29 pm Sale | 2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO | James E. Flynn | 2,161,000 5.010% | -208,166 (-8.79%) | Filing History |
| 2021-02-11 2:30 pm Sale | 2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO | Renaissance Technologies LLC | 2,313,864 5.370% | -972,848 (-29.60%) | Filing History |
| 2021-02-10 11:28 am Purchase | 2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO | The Vanguard Group | 4,757,715 11.030% | 155,889 (+3.39%) | Filing History |
| 2021-01-25 4:50 pm Sale | 2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO | BlackRock Inc. BLK | 6,847,747 15.900% | -58,462 (-0.85%) | Filing History |
| 2020-10-26 5:08 pm Purchase | 2020-10-16 | 13G | Meridian Bioscience, Inc. VIVO | James E. Flynn | 2,369,166 5.530% | 2,369,166 (New Position) | Filing History |